Menu

Fresh off raising $1.8M, Chapel Hill startup preps for $8 million


Chapel Hill-based startup Renovion – which is developing a nebulized therapy called Arina-1 for the treatment of lung transplant patients– has its eyes on submitting a New Drug Application to the U.S. Food and Drug Administration in early 2019, according to chief executive officer Dan Copeland. (Triangle Business Journal)

Related:

New UNC Humanities Scholarship Formed by $10 Million Gift
Stephen Israel, a former vice chairman of the consulting firm Korn Ferry and UNC graduate in the Class of 1966, gifted $10 million to the...

Women's History Month At Carolina
More than half of the Tar Heels enrolled at the University of North Carolins at Chapel Hill today are women, but that hasn’t always been...

Downtown Starbucks To Relocate on East Franklin Street in Chapel Hill
The Starbucks in downtown Chapel Hill is set to relocate, but it won’t be going far. In fact, it will be just across the street...

Manchester City, Celtic FC To Play Exhibition Match at Kenan Stadium in July
The beautiful game is returning to Kenan Stadium. English soccer champions Manchester City, one of the most successful clubs in the world, and Scottish side...


© 2005-2024 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.